Tinklenberg J - Search Results

1

The brain-derived neurotrophic factor Val66Met polymorphism and rate of decline in Alzheimer's disease.

Chuu JY, Taylor JL, Tinklenberg J, Noda A, Yesavage J, Murphy GM Jr. Chuu JY, et al. Among authors: tinklenberg j. J Alzheimers Dis. 2006 Mar;9(1):43-9. doi: 10.3233/jad-2006-9104. J Alzheimers Dis. 2006. PMID: 16627933

2

On disentangling states versus traits: demonstration of a new technique using the Alzheimer's disease assessment scale.

Taylor JL, Kraemer HC, Noda A, Friedman L, Zarcone V, Tinklenberg JR, Yesavage JA. Taylor JL, et al. Alzheimer Dis Assoc Disord. 2002 Oct-Dec;16(4):254-60. doi: 10.1097/00002093-200210000-00007. Alzheimer Dis Assoc Disord. 2002. PMID: 12468900

3

Memantine is associated with longer survival than donepezil in a Veterans Affairs prescription database, 1997 to 2008.

Lazzeroni LC, Halbauer JD, Ashford JW, Noda A, Hernandez B, Azor V, Hozack N, Hasson N, Henderson VW, Yesavage JA, Tinklenberg JR. Lazzeroni LC, et al. Among authors: tinklenberg jr. J Alzheimers Dis. 2013;36(4):791-8. doi: 10.3233/JAD-130662. J Alzheimers Dis. 2013. PMID: 23703151

4

Development of aphasia, apraxia, and agnosia and decline in Alzheimer's disease.

Yesavage JA, Brooks JO 3rd, Taylor J, Tinklenberg J. Yesavage JA, et al. Among authors: tinklenberg j. Am J Psychiatry. 1993 May;150(5):742-7. doi: 10.1176/ajp.150.5.742. Am J Psychiatry. 1993. PMID: 8480819

5

Cognitive decline in patients with Alzheimer disease: differences in patients with and without extrapyramidal signs.

Miller TP, Tinklenberg JR, Brooks JO 3rd, Yesavage JA. Miller TP, et al. Among authors: tinklenberg jr. Alzheimer Dis Assoc Disord. 1991 Winter;5(4):251-6. doi: 10.1097/00002093-199100540-00004. Alzheimer Dis Assoc Disord. 1991. PMID: 1781967

6

Rate of cognitive decline in Alzheimer's disease is not affected by the alpha-1-antichymotrypsin A allele or the CYP2D6 B mutant.

Murphy GM Jr, Yang L, Yesavage J, Tinklenberg JR. Murphy GM Jr, et al. Among authors: tinklenberg jr. Neurosci Lett. 1996 Oct 18;217(2-3):200-2. Neurosci Lett. 1996. PMID: 8916107 Free article. Clinical Trial.

7

No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.

Murphy GM Jr, Taylor J, Kraemer HC, Yesavage J, Tinklenberg JR. Murphy GM Jr, et al. Among authors: tinklenberg jr. Am J Psychiatry. 1997 May;154(5):603-8. doi: 10.1176/ajp.154.5.603. Am J Psychiatry. 1997. PMID: 9137113

8

Rate of cognitive decline in AD is accelerated by the interleukin-1 alpha -889 *1 allele.

Murphy GM Jr, Claassen JD, DeVoss JJ, Pascoe N, Taylor J, Tinklenberg JR, Yesavage JA. Murphy GM Jr, et al. Among authors: tinklenberg jr. Neurology. 2001 Jun 12;56(11):1595-7. doi: 10.1212/wnl.56.11.1595. Neurology. 2001. PMID: 11402127

9

Structural brain alterations before mild cognitive impairment in ADNI: validation of volume loss in a predefined antero-temporal region.

Smith CD, Andersen AH, Gold BT; Alzheimer's Disease Neuroimaging Initiative. Smith CD, et al. J Alzheimers Dis. 2012;31 Suppl 3(0 3):S49-58. doi: 10.3233/JAD-2012-120157. J Alzheimers Dis. 2012. PMID: 22460332 Free PMC article.

10

CFH Variants Affect Structural and Functional Brain Changes and Genetic Risk of Alzheimer's Disease.

Zhang DF, Li J, Wu H, Cui Y, Bi R, Zhou HJ, Wang HZ, Zhang C, Wang D; Alzheimer's Disease Neuroimaging Initiative (ADNI); Kong QP, Li T, Fang Y, Jiang T, Yao YG. Zhang DF, et al. Neuropsychopharmacology. 2016 Mar;41(4):1034-45. doi: 10.1038/npp.2015.232. Epub 2015 Aug 5. Neuropsychopharmacology. 2016. PMID: 26243271 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

420 results

Search Page

Filters